Your provider can help you decide between reaching a goal weight then stopping, or transitioning to a maintenance dose you take indefinitely
Individual responses to GLP-1 can differ greatly
Because great results start with honesty, not pressure
The utilization of domperidone, erythromycin, and mosapride (a 5-hydroxy tryptamine 4 agonist) is limited owing to safety concerns (Fleming et al., 2020
Other research suggests this phenomenon is at least partly due to the fact that the majority of the energy it takes to run is used to support your bodyweightnot drive it forward
The EMPA-KIDNEY, Collaborative G, Herrington WG, Staplin N, Wanner C, Green JB, Hauske SJ, Emberson JR, Preiss D, Judge P, Mayne KJ, Ng SYA, Sammons E, Zhu D, Hill M, Stevens W, Wallendszus K, Brenner S, Cheung AK, Liu ZH, Li J, Hooi LS, Liu W, Kadowaki T, Nangaku M, Levin A, Cherney D, Maggioni AP, Pontremoli R, Deo R, Goto S, Rossello X, Tuttle KR, Steubl D, Petrini M, Massey D, Eilbracht J, Brueckmann M, Landray MJ, Baigent C, Haynes R